Not for sale, not even for rent: Just say no. Thoughts about the American College of Rheumatology adopting a code of ethics

Journal of Rheumatology

Volumn 29, Issue 5, 2002, Pages 1049-1057

  Panush, Richard S ^a  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BENOXAPROFEN; INCREDUMAX; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL; UNCLASSIFIED DRUG;

CONFLICT; DOCTOR PATIENT RELATION; DRUG CHOICE; DRUG INDICATION; DRUG MARKETING; HEALTH CARE QUALITY; HUMAN; LEADERSHIP; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL SOCIETY; PATIENT CARE; PATIENT GUIDANCE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; REVIEW; RHEUMATIC DISEASE; RHEUMATOLOGY; STANDARD;

BIOETHICS AND PROFESSIONAL ETHICS;

CODES OF ETHICS; HUMANS; RHEUMATOLOGY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0036246470     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Professional medical associations. Ethical and practical guidelines
2. Introduction to miscellaneous topics
3. A rude awakening
4. Separating continuing medical education from pharmaceutical marketing
5. Is academic medicine for sale?
6. Financial indigestion
7. Conflicts of interest in biomedical research
8. Conflict of interest and the public trust
9. Pseudoaccountability
10. When physicians double as entrepreneurs. Hidden interests
11. From the president
12. Doctors, drug companies and gifts
13. Opren scandal
14. Doctors and the drug makers
15. Doctors and the drug industry: Too close for comfort
16. Undesirable marketing practices in the pharmaceutical industry
17. Sounding board: A matter of influence
18. Frequent-flyer programs for drug prescribing
19. Pitching doctors
20. Pushing drugs to doctors
21. Drug firms faulted for coaxing MDs to push products via cruises, gifts
22. Kennedy hearings say no more free lunch-or much else - From drug firms
23. Ethics of receiving gifts considered
24. Sounding board: Industrial marketing and medical ethics
25. Physicians and the pharmaceutical industry
26. AAFP Congress approves statement on ethics of proprietary relationships
27. ACR adopts new guidelines on industry relations
28. Drug company gifts to physicians to be curbed
29. The relationship between physicians and the pharmaceutical industry. A report of the Royal College of Physicians
30. Student reactions to pharmaceutical promotion practices
31. Drug promotion in a family medicine training center
32. The gift relationship between pharmaceutical companies and physicians: An exploratory survey of physicians
33. Patients' attitudes about gifts to physicians from pharmaceutical companies
34. Gifts to physicians from industry
35. The pizza parade
36. Gifts to physicians from industry
37. Pharmaceutical promotions - A free lunch?
38. Sample pharmaceuticals
39. Physicians and the pharmaceutical industry
40. AAFP White Paper on Proprietary Relationships: Just do the right thing
41. Gifts to physicians from industry
42. Gift and gratuity in ethics
43. The ethics of accepting gifts from pharmaceutical companies
44. An Engelhardtian analysis of interactions between pharmaceutical sales representatives and physicians
45. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives
46. Pharmaceutical representatives and emergency medicine residents: A national survey
47. Attitudes of medical school faculty toward gifts from the pharmaceutical industry
48. Pharmaceutical representatives in academic medical centers
49. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities
50. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives
51. Physicians' behavior and their interactions with drug companies
52. The quality of drug studies published in symposium proceedings
53. A comparison of physicians' and patients' attitude
54. Interactions between physicians and the pharmaceutical industry: What does the literature say?
55. Physicians, pharmaceutical sales representatives, and the cost of prescribing
56. Patient perceptions of physician acceptance of gifts from the pharmaceutical industry
57. The effects of pharmaceutical firm enticements on physician prescribing patterns
58. Characteristics of materials distributed by drug companies. An evaluation of appropriateness
59. Do pharmaceutical representatives misuse their drug samples?
60. The accuracy of drug information from pharmaceutical sales representatives
61. Conflict of interest in the debate over calcium-channel antagonists
62. Scientific versus commercial sources of influence on the prescribing behavior of physicians
63. Primary care physicians believe that calcium channel blockers and ACE inhibitors are similar to B-blocker and diuretics in treating unimplicated hypertension
64. The pharmaceutical industry's influence on chief medical residents
65. Encounters with pharmaceutical sales representatives around practicing internists
66. Interactions between physicians and drug company representatives
67. The American College of Rheumatology as a "professional" society
68. On professionalism